Lung Function
30
2
3
18
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 30 trials
100.0%
+13.5% vs benchmark
7%
2 trials in Phase 3/4
11%
2 of 18 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 18 completed trials
Clinical Trials (30)
Comparative Effects of Triple Inhaled Therapy With Budesonide/Glycopyrronium/Formoterol Versus Fluticasone Furoate/Umeclidinium/Vilanterol on Small Airway Disease in COPD Patients: A Randomized Crossover Study
Cost Effective Air Filtration Intervention in Low-Income Housing to Reduce Asthma Morbidity
Sustainable Household Energy Adoption in Rwanda (SHEAR)
Acute Effects of Low Temperature Exposure on Respiratory System
Early-life MRI Biomarkers of Longer-term Respiratory Morbidity in Infants Born Extremely Preterm (EMBLEM)
Manual Diaphragmatic Release on Ventilatory Functions in Women With Rheumatoid Arthritis
Lung Function, Exercise Capacity, and Serology Responses in Patients With COVID-19
The Role of Eicosanoids in the Cardiovascular Actions of Inhaled Nanoparticles
Combining Manual Soft Tissue Release and Exercise Training in COPD: the Effect on LF, EC, and CAF
Respiratory Effects of Flow-Controlled Ventilation and Jet Ventilation in Patients Undergoing Laryngotracheal Surgery
Lung Function After Abdominal Surgery
The Use of Air Cleaners to Mitigate Cardiopulmonary Health Impact of Indoor Exposure to Particles and Phthalates
Telerehabilitation and Face-to-face Rehabilitation on COVID-19 Survivors
Continuous Positive Airway Pressure After Abdominal Surgery
Significance of Early Mobilization After VATS-L
Clinical Characteristics, Treatment and Prognosis of Chest Tightness Variant Asthma
Clinical Characteristics and Treatment of Chest Tightness Variant Asthma
Acute Health Effects of Passive Vape Among COPD Patients
Float First: An Index of Floating: Factors Affecting Floating in Different Populations
Lung Function Decline and Disease Risk From Young Adulthood to Middle Age